Dark

FLXN
Horizon Flexible Income ETF
stock BATS ETF

At Close

Dec 17, 2025 11:09:57 AM EST

25.97USD0.000%(0.00)2,510

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-25.97)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsMore

open chart

Market Cap

1.31B

CEO

Michael Clayman

Headquarters

Burlington, Massachusetts, USA

Industry

Drug Manufacturers-Specialty & Generic

JNJ PFE PCRX ACRX INSY AMPE REPH CARA XLV

FLXN Stats

Avg. Vol. 10 Day

18,599

Avg. Vol. 30 Day

7,655

Employees

257

Market Cap

1,309,829,600

Shares Out.

50,320,000

On/Off Exchange

10%/90%

6 Month Beta

0.33

3 Year Beta

2.57

52 Week Low

24.92

52 Week High

26.04

SMA50

25.72

SMA200

17.85

1 Week

+0.02%

1 Month

+2.41%

3 Month

+1.54%

6 Month

+3.79%

5 Year

+129.54%

Profile

Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun.

FLXN Stock Summary

Horizon Flexible Income ETF (BATS:FLXN) stock price today is $25.97, and today's volume is 2,510. FLXN is down 0.000% today. The 30 day average volume is 7,655. FLXN market cap is 1.31B with 50,320,000 shares outstanding.